# An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus

> **NCT03252587** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 363 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** BMS-986165
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03252587
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-21
- **Primary completion:** 2021-06-29
- **Final completion:** 2021-10-28
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252587, "An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03252587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*